XClose

UCL School of Pharmacy

Home
Menu

Professor Ijeoma Uchegbu

Professor of Pharmaceutical Nanoscience

Tel: 020 7753 5997
ijeoma.uchegbu@ucl.ac.uk

Research interests

  • Polymer amphiphile design and synthesis
  • Polymer self assembly
  • Nanomedicines design and fabrication
  • Nanodiagnostics design and fabrication
  • Delivery of peptides and macromolecules to the brain
  • Oral absorption of drugs

Teaching interests

  • Teaching on the Biopharmaceuticals and Nanomedicine modules

Current collaborations and partnerships

  • Nanomerics Ltd - the development of METDoloron, a pain therapeutic
  • AMT Ltd. - the flow synthesis of polymer amphiphiles
  • Professor Andreas G. Schatzlein (UCL School of Pharmacy) - nanomedicines design, fabrication and testing
  • Dr Julian Moger (Physics, Exeter University) - the mechanistic understanding of Nanomerics MET drug delivery platform
  • Dr Susan Alexander (UCL Surgery and Interventional Sciences) and Professor Robert Brown (UCL Surgery and Interventional Sciences) – the design and fabrication of antibiotic therapeutic entities
  • Dr Marilena Lozouidou (UCL Surgery and Interventional Sciences) - the development of cancer diagnostics
  • Professor Thanh Nguyen (UCL Physics and Astronomy) and AstraZeneca – the development of targeted theranostics

Education

PhD, The School of Pharmacy, University of London

Prof Ijeoma Uchegbu

Address

326b
29 - 39 Brunswick Square
London
WC1N 1AX

Appointments

  • Professor
    Pharmaceutics
    UCL School of Pharmacy

Joined UCL

2006-09-01

Research in the Pharmaceutical Nanoscience group exploits fundamental physical chemistry principles to fabricate functional pharmaceutical nanoparticles - nanomedicines.  Our output stretches seamlessly from molecular design of functional pharmaceutical excipients to the dosage form's in vivo characteristics.  Our group designs and synthesises polymers which self assemble into tailored nanoparticles with the predictable, morphology, size, drug loading and drug transport properties.  We have been successful in designing pharmaceutical nanosystems which deliver: genes and siRNA to tumours, peptides to the brain via the oral and intravenous routes and nanoparticles facilitate the oral absorption of hydrophobic drugs.  Our work is being commercialised via a UCL spin out company - Nanomerics Ltd. 

Ijeoma Uchegbu is Professor of Pharmaceutical Nanoscience within the UCL School of Pharmacy.  She obtained her PhD from the School of Pharmacy in 1994 and was appointed to a lectureship in Drug Delivery in 1997 within the University of Strathclyde.  She became a senior lecturer in 2000 and a Professor of Drug Delivery in 2002.  She then joined the School of Pharmacy as a Professor of Pharmaceutical Nanoscience in 2006 and joined UCL in 2012.  In 2010 Ijeoma became cofounder Chief Scientific Officer of Nanomerics Ltd, a specialty pharmaceutical company and spin out from UCL.  Ijeoma has won numerous prizes for her work including the UK's Department of Business Innovation and Skills' Women of Outstanding Achievement Award in 2007 and the Royal Pharmaceutical Society's Pharmaceutical Scientist of the Year Award in 2012.